热门资讯> 正文
Nuvectis Pharma宣布公开募股以支持药物计划
2026-06-30 04:10
- Nuvectis Pharma (NVCT) announced on Monday that it has launched an underwritten public offering of its common stock.
- The underwriters will have a 30-day option to purchase up to an additional 15% of the shares offered by the company.
- The company said the offering remains subject to market conditions and other factors, with the final size, pricing, and terms yet to be determined.
- Nuvectis plans to use the net proceeds to advance the development of its NXP100, NXP200, and NXP900 programs, along with any future product candidates.
- The remaining funds will also support new hiring, capital expenditures, public company operating expenses, and other general corporate purposes.
- Source: Press Release
More on Nuvectis Pharma
- Nuvectis Pharma, Inc. (NVCT) Discusses Strategic In-Licensing Deal and Expansion Into Complement-Mediated Diseases and Oncology Prepared Remarks Transcript
- Seeking Alpha’s Quant Rating on Nuvectis Pharma
- Historical earnings data for Nuvectis Pharma
- Financial information for Nuvectis Pharma
推荐文章
港股周报 | 科技股遭遇“黑色一周”！智谱、兆易创新周内分别重挫32%、28%；韩国去杠杆再掀芯片股风暴；“大空头”喊话布局港股
美股前瞻 | 抛售潮蔓延？纳指期货跌近2%，“恐慌指数”跳涨逾9%创周内新高；取消“星舰”试飞！SpaceX空头仓位大幅攀升
一周财经日历 | 超级财报周！特斯拉、英特尔、宁德将公布业绩；特朗普出席白宫记协晚宴，讲话或影响市场
华盛早报 | 存储概念遭抛售潮！SK海力士ADR暴跌13%；SpaceX星舰试飞取消股价破发；奈飞绩后跌逾9%
7月17日外盘头条：美国对伊朗发动新一轮打击 苹果拟对iPad mini进行升级 堪萨斯城联储行长称美国通胀过热
谷歌据悉推迟发布Gemini 3.5 Pro 因持续提升模型编程能力
闪迪股价持续下跌的背后原因
苹果拟对iPad mini进行五年来最大规模升级 今年秋季发布新品
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
